Latest News & Updates
Breaking News
13 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Genelux Strengthens Leadership With Appointment Of Dr. Jason Litten As CMO To Advance Late-Stage Trials Of Olvi-Vec
Genelux appoints oncology veteran Jason Litten as CMO to guide clinical strategy for its lead immunotherapy candidate Olvi-Vec.
Simantini Singh Deo
Theriva Biologics Gets Positive EMA Scientific Advice For Phase 3 Trial Design Of VCN-01 In Metastatic Pancreatic Ductal Adenocarcinoma
Theriva secures EMA CHMP guidance endorsing a Phase 3 study of VCN-01 with chemotherapy for metastatic PDAC.
Simantini Singh Deo
SELLAS Life Sciences Issues Update On Pivotal Phase 3 REGAL Trial Evaluating Galinpepimut-S (GPS) For Acute Myeloid Leukemia
SELLAS shares progress on the Phase 3 REGAL study of GPS in acute myeloid leukemia, with overall survival events still accruing.
Simantini Singh Deo
Praxis Precision Medicines Wins FDA Breakthrough Therapy Designation For Ulixacaltamide, A Selective T-Type Calcium Channel Inhibitor For Essential Tremor
Praxis receives FDA Breakthrough Therapy Designation for ulixacaltamide, a novel T-type calcium channel inhibitor for essential tremor.
Simantini Singh Deo
